U.S. Markets open in 16 hrs, 5 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,288.54 | 73.03 | 0.65% |
| NASDAQ | 2,245.38 | -6.08 | -0.27% |
| S&P 500 | 1,262.90 | 1.38 | 0.11% |
| Day Low 11:08 AM EDT | 27.14 | |
|---|---|---|
| Day High 09:35 AM EDT | 27.54 |
|
| Range | 0.40 | |
| Volume | 422,870 | |
| 30-Day Avg. Vol. | 830,000 |
|
| Difference | -49.05% | |
| Market Cap. | 2.84 B | |
| Change | 8.35 M | |
| Shares Out. | 104.44 M | |
| Percent Traded | 0.40% | |
| Revenue | 2.49 B | |
| Earnings | 141.03 M | |
| EPS (TTM) | 1.43 |
| 52-Wk Low 1/22/08 | 23.90 | |
|---|---|---|
| 52-Wk High 7/17/07 | 33.91 |
|
| Range | 10.01 | |
| Prev. Close 7/2/08 | 27.17 | |
| Today's Open | 27.39 | |
| Change | 0.81% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 0.9115 | |
| P/E Ratio (TTM) | 19.06 | |
| P/E Ratio (Fwd.) | — |
Watson Pharmaceuticals tries to have the best of both worlds, with operations in the US generics market and the higher-profit-margin branded drug business. The company's broad generics portfolio of about ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | 0.313 12/31/07 | 0.35 12/31/07 |
0.037
Beat
|
| Last Quarter | 0.518 3/31/08 | 0.55 3/31/08 |
0.032
Beat
|
| Quarterly - 03/31/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 626.95 M | 2.50 B |
| Gross Profit | 226.67 M | 815.49 M |
| Operating Income | 82.02 M | 315.84 M |
| Net Income | 50.63 M | 141.03 M |
